3083307-47-2

(R)-AR/BRD4 RIPTAC-1 Chemical Structure
3083307-47-2

Chemical Structure

(R)-AR/BRD4 RIPTAC-1

  • CAS No.: 3083307-47-2
  • Formula:C50H54N10O5S
  • Molecular Weight:907.09

InChIKey: PVYWAVIGWFSXIT-BMWAMRAGSA-N

SMILES: N#CC1=C(OC)C=C(O[C@@H]2C(C)(C)[C@@H](NC(C3=CN=C(N4CCC5(CC(OC6=CC=C(C7=N[C@H](CC8=NC=CO8)C9=NN=C(C)N9C%10=C7C(C)=C(C)S%10)C=C6)C5)CC4)N=C3)=O)C2(C)C)C=C1

Biological Activity: (R)-AR/BRD4 RIPTAC-1 is the R-enantiomer of AR/BRD4 RIPTAC-1 (HY-176521). AR/BRD4 RIPTAC-1 is an orally active Regulated Induced Proximity TArgeting Chimera (RIPTAC). AR/BRD4 RIPTAC-1 induces the formation of a stable ternary complex between the androgen receptor (AR) and BRD4, thereby blocking BRD4 function. AR/BRD4 RIPTAC-1 inhibits the growth and proliferation of tumor cells. AR/BRD4 RIPTAC-1 holds promise for research into prostate cancer.

Cat. No. Product Name Purity Description Pricing
HY-176521B
(R)-AR/BRD4 RIPTAC-1 (R)-AR/BRD4 RIPTAC-1 is the R-enantiomer of AR/BRD4 RIPTAC-1 (HY-176521). AR/BRD4 RIPTAC-1 is an orally active Regulated Induced Proximity TArgeting Chimera (RIPTAC). AR/BRD4 RIPTAC-1 induces the formation of a stable ternary complex between the androgen receptor (AR) and BRD4, thereby blocking BRD4 function. AR/BRD4 RIPTAC-1 inhibits the growth and proliferation of tumor cells. AR/BRD4 RIPTAC-1 holds promise for research into prostate cancer.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide